Pre-order Enquiry
Request Free Sample
Global Herceptin (Trastuzumab) Market Growth 2022-2028
SKU ID : LPI-20500109 | Publishing Date : 15-Mar-2022
Request Sample
Request Customization
Check DiscountsDetailed TOC of Global Herceptin (Trastuzumab) Market Growth 2022-2028
1 Scope of the Report1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Herceptin (Trastuzumab) Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Herceptin (Trastuzumab) by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Herceptin (Trastuzumab) by Country/Region, 2017, 2022 & 2028
2.2 Herceptin (Trastuzumab) Segment by Type
2.2.1 Breast Cancer
2.2.2 Stomach Cancer
2.2.3 Others
2.3 Herceptin (Trastuzumab) Sales by Type
2.3.1 Global Herceptin (Trastuzumab) Sales Market Share by Type (2017-2022)
2.3.2 Global Herceptin (Trastuzumab) Revenue and Market Share by Type (2017-2022)
2.3.3 Global Herceptin (Trastuzumab) Sale Price by Type (2017-2022)
2.4 Herceptin (Trastuzumab) Segment by Application
2.4.1 Hospital
2.4.2 Medical Center
2.5 Herceptin (Trastuzumab) Sales by Application
2.5.1 Global Herceptin (Trastuzumab) Sale Market Share by Application (2017-2022)
2.5.2 Global Herceptin (Trastuzumab) Revenue and Market Share by Application (2017-2022)
2.5.3 Global Herceptin (Trastuzumab) Sale Price by Application (2017-2022)
3 Global Herceptin (Trastuzumab) by Company
3.1 Global Herceptin (Trastuzumab) Breakdown Data by Company
3.1.1 Global Herceptin (Trastuzumab) Annual Sales by Company (2020-2022)
3.1.2 Global Herceptin (Trastuzumab) Sales Market Share by Company (2020-2022)
3.2 Global Herceptin (Trastuzumab) Annual Revenue by Company (2020-2022)
3.2.1 Global Herceptin (Trastuzumab) Revenue by Company (2020-2022)
3.2.2 Global Herceptin (Trastuzumab) Revenue Market Share by Company (2020-2022)
3.3 Global Herceptin (Trastuzumab) Sale Price by Company
3.4 Key Manufacturers Herceptin (Trastuzumab) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Herceptin (Trastuzumab) Product Location Distribution
3.4.2 Players Herceptin (Trastuzumab) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Herceptin (Trastuzumab) by Geographic Region
4.1 World Historic Herceptin (Trastuzumab) Market Size by Geographic Region (2017-2022)
4.1.1 Global Herceptin (Trastuzumab) Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Herceptin (Trastuzumab) Annual Revenue by Geographic Region
4.2 World Historic Herceptin (Trastuzumab) Market Size by Country/Region (2017-2022)
4.2.1 Global Herceptin (Trastuzumab) Annual Sales by Country/Region (2017-2022)
4.2.2 Global Herceptin (Trastuzumab) Annual Revenue by Country/Region
4.3 Americas Herceptin (Trastuzumab) Sales Growth
4.4 APAC Herceptin (Trastuzumab) Sales Growth
4.5 Europe Herceptin (Trastuzumab) Sales Growth
4.6 Middle East & Africa Herceptin (Trastuzumab) Sales Growth
5 Americas
5.1 Americas Herceptin (Trastuzumab) Sales by Country
5.1.1 Americas Herceptin (Trastuzumab) Sales by Country (2017-2022)
5.1.2 Americas Herceptin (Trastuzumab) Revenue by Country (2017-2022)
5.2 Americas Herceptin (Trastuzumab) Sales by Type
5.3 Americas Herceptin (Trastuzumab) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Herceptin (Trastuzumab) Sales by Region
6.1.1 APAC Herceptin (Trastuzumab) Sales by Region (2017-2022)
6.1.2 APAC Herceptin (Trastuzumab) Revenue by Region (2017-2022)
6.2 APAC Herceptin (Trastuzumab) Sales by Type
6.3 APAC Herceptin (Trastuzumab) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Herceptin (Trastuzumab) by Country
7.1.1 Europe Herceptin (Trastuzumab) Sales by Country (2017-2022)
7.1.2 Europe Herceptin (Trastuzumab) Revenue by Country (2017-2022)
7.2 Europe Herceptin (Trastuzumab) Sales by Type
7.3 Europe Herceptin (Trastuzumab) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Herceptin (Trastuzumab) by Country
8.1.1 Middle East & Africa Herceptin (Trastuzumab) Sales by Country (2017-2022)
8.1.2 Middle East & Africa Herceptin (Trastuzumab) Revenue by Country (2017-2022)
8.2 Middle East & Africa Herceptin (Trastuzumab) Sales by Type
8.3 Middle East & Africa Herceptin (Trastuzumab) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Herceptin (Trastuzumab)
10.3 Manufacturing Process Analysis of Herceptin (Trastuzumab)
10.4 Industry Chain Structure of Herceptin (Trastuzumab)
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Herceptin (Trastuzumab) Distributors
11.3 Herceptin (Trastuzumab) Customer
12 World Forecast Review for Herceptin (Trastuzumab) by Geographic Region
12.1 Global Herceptin (Trastuzumab) Market Size Forecast by Region
12.1.1 Global Herceptin (Trastuzumab) Forecast by Region (2023-2028)
12.1.2 Global Herceptin (Trastuzumab) Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Herceptin (Trastuzumab) Forecast by Type
12.7 Global Herceptin (Trastuzumab) Forecast by Application
13 Key Players Analysis
13.1 Roche Diagnostics
13.1.1 Roche Diagnostics Company Information
13.1.2 Roche Diagnostics Herceptin (Trastuzumab) Product Offered
13.1.3 Roche Diagnostics Herceptin (Trastuzumab) Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Roche Diagnostics Main Business Overview
13.1.5 Roche Diagnostics Latest Developments
13.2 Genentech
13.2.1 Genentech Company Information
13.2.2 Genentech Herceptin (Trastuzumab) Product Offered
13.2.3 Genentech Herceptin (Trastuzumab) Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Genentech Main Business Overview
13.2.5 Genentech Latest Developments
13.3 Novartis AG
13.3.1 Novartis AG Company Information
13.3.2 Novartis AG Herceptin (Trastuzumab) Product Offered
13.3.3 Novartis AG Herceptin (Trastuzumab) Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Novartis AG Main Business Overview
13.3.5 Novartis AG Latest Developments
13.4 Pfizer
13.4.1 Pfizer Company Information
13.4.2 Pfizer Herceptin (Trastuzumab) Product Offered
13.4.3 Pfizer Herceptin (Trastuzumab) Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Pfizer Main Business Overview
13.4.5 Pfizer Latest Developments
13.5 Abnova Corporation
13.5.1 Abnova Corporation Company Information
13.5.2 Abnova Corporation Herceptin (Trastuzumab) Product Offered
13.5.3 Abnova Corporation Herceptin (Trastuzumab) Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Abnova Corporation Main Business Overview
13.5.5 Abnova Corporation Latest Developments
13.6 InvivoGen
13.6.1 InvivoGen Company Information
13.6.2 InvivoGen Herceptin (Trastuzumab) Product Offered
13.6.3 InvivoGen Herceptin (Trastuzumab) Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 InvivoGen Main Business Overview
13.6.5 InvivoGen Latest Developments
13.7 Celltrion
13.7.1 Celltrion Company Information
13.7.2 Celltrion Herceptin (Trastuzumab) Product Offered
13.7.3 Celltrion Herceptin (Trastuzumab) Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Celltrion Main Business Overview
13.7.5 Celltrion Latest Developments
13.8 Biocon Limited
13.8.1 Biocon Limited Company Information
13.8.2 Biocon Limited Herceptin (Trastuzumab) Product Offered
13.8.3 Biocon Limited Herceptin (Trastuzumab) Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Biocon Limited Main Business Overview
13.8.5 Biocon Limited Latest Developments
13.9 Bio-Techne
13.9.1 Bio-Techne Company Information
13.9.2 Bio-Techne Herceptin (Trastuzumab) Product Offered
13.9.3 Bio-Techne Herceptin (Trastuzumab) Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Bio-Techne Main Business Overview
13.9.5 Bio-Techne Latest Developments
13.10 Amgen
13.10.1 Amgen Company Information
13.10.2 Amgen Herceptin (Trastuzumab) Product Offered
13.10.3 Amgen Herceptin (Trastuzumab) Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Amgen Main Business Overview
13.10.5 Amgen Latest Developments
13.11 Samsung Bioepis
13.11.1 Samsung Bioepis Company Information
13.11.2 Samsung Bioepis Herceptin (Trastuzumab) Product Offered
13.11.3 Samsung Bioepis Herceptin (Trastuzumab) Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Samsung Bioepis Main Business Overview
13.11.5 Samsung Bioepis Latest Developments
13.12 Merck
13.12.1 Merck Company Information
13.12.2 Merck Herceptin (Trastuzumab) Product Offered
13.12.3 Merck Herceptin (Trastuzumab) Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Merck Main Business Overview
13.12.5 Merck Latest Developments
13.13 Mylan
13.13.1 Mylan Company Information
13.13.2 Mylan Herceptin (Trastuzumab) Product Offered
13.13.3 Mylan Herceptin (Trastuzumab) Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Mylan Main Business Overview
13.13.5 Mylan Latest Developments
13.14 Teva Pharmaceutical
13.14.1 Teva Pharmaceutical Company Information
13.14.2 Teva Pharmaceutical Herceptin (Trastuzumab) Product Offered
13.14.3 Teva Pharmaceutical Herceptin (Trastuzumab) Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Teva Pharmaceutical Main Business Overview
13.14.5 Teva Pharmaceutical Latest Developments
13.15 Mundipharma
13.15.1 Mundipharma Company Information
13.15.2 Mundipharma Herceptin (Trastuzumab) Product Offered
13.15.3 Mundipharma Herceptin (Trastuzumab) Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Mundipharma Main Business Overview
13.15.5 Mundipharma Latest Developments
13.16 Mabion
13.16.1 Mabion Company Information
13.16.2 Mabion Herceptin (Trastuzumab) Product Offered
13.16.3 Mabion Herceptin (Trastuzumab) Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 Mabion Main Business Overview
13.16.5 Mabion Latest Developments
13.17 AryoGen Biopharma
13.17.1 AryoGen Biopharma Company Information
13.17.2 AryoGen Biopharma Herceptin (Trastuzumab) Product Offered
13.17.3 AryoGen Biopharma Herceptin (Trastuzumab) Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 AryoGen Biopharma Main Business Overview
13.17.5 AryoGen Biopharma Latest Developments
13.18 Genor Biopharma
13.18.1 Genor Biopharma Company Information
13.18.2 Genor Biopharma Herceptin (Trastuzumab) Product Offered
13.18.3 Genor Biopharma Herceptin (Trastuzumab) Sales, Revenue, Price and Gross Margin (2020-2022)
13.18.4 Genor Biopharma Main Business Overview
13.18.5 Genor Biopharma Latest Developments
14 Research Findings and Conclusion
List of Figures, Tables and Charts Available in Global Herceptin (Trastuzumab) Market Growth 2022-2028
List of TablesTable 1. Herceptin (Trastuzumab) Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Herceptin (Trastuzumab) Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Breast Cancer
Table 4. Major Players of Stomach Cancer
Table 5. Major Players of Others
Table 6. Global Herceptin (Trastuzumab) Sales by Type (2017-2022) & (K Units)
Table 7. Global Herceptin (Trastuzumab) Sales Market Share by Type (2017-2022)
Table 8. Global Herceptin (Trastuzumab) Revenue by Type (2017-2022) & ($ million)
Table 9. Global Herceptin (Trastuzumab) Revenue Market Share by Type (2017-2022)
Table 10. Global Herceptin (Trastuzumab) Sale Price by Type (2017-2022) & (K USD/Unit)
Table 11. Global Herceptin (Trastuzumab) Sales by Application (2017-2022) & (K Units)
Table 12. Global Herceptin (Trastuzumab) Sales Market Share by Application (2017-2022)
Table 13. Global Herceptin (Trastuzumab) Revenue by Application (2017-2022)
Table 14. Global Herceptin (Trastuzumab) Revenue Market Share by Application (2017-2022)
Table 15. Global Herceptin (Trastuzumab) Sale Price by Application (2017-2022) & (K USD/Unit)
Table 16. Global Herceptin (Trastuzumab) Sales by Company (2020-2022) & (K Units)
Table 17. Global Herceptin (Trastuzumab) Sales Market Share by Company (2020-2022)
Table 18. Global Herceptin (Trastuzumab) Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Herceptin (Trastuzumab) Revenue Market Share by Company (2020-2022)
Table 20. Global Herceptin (Trastuzumab) Sale Price by Company (2020-2022) & (K USD/Unit)
Table 21. Key Manufacturers Herceptin (Trastuzumab) Producing Area Distribution and Sales Area
Table 22. Players Herceptin (Trastuzumab) Products Offered
Table 23. Herceptin (Trastuzumab) Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Herceptin (Trastuzumab) Sales by Geographic Region (2017-2022) & (K Units)
Table 27. Global Herceptin (Trastuzumab) Sales Market Share Geographic Region (2017-2022)
Table 28. Global Herceptin (Trastuzumab) Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Herceptin (Trastuzumab) Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Herceptin (Trastuzumab) Sales by Country/Region (2017-2022) & (K Units)
Table 31. Global Herceptin (Trastuzumab) Sales Market Share by Country/Region (2017-2022)
Table 32. Global Herceptin (Trastuzumab) Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Herceptin (Trastuzumab) Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Herceptin (Trastuzumab) Sales by Country (2017-2022) & (K Units)
Table 35. Americas Herceptin (Trastuzumab) Sales Market Share by Country (2017-2022)
Table 36. Americas Herceptin (Trastuzumab) Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Herceptin (Trastuzumab) Revenue Market Share by Country (2017-2022)
Table 38. Americas Herceptin (Trastuzumab) Sales by Type (2017-2022) & (K Units)
Table 39. Americas Herceptin (Trastuzumab) Sales Market Share by Type (2017-2022)
Table 40. Americas Herceptin (Trastuzumab) Sales by Application (2017-2022) & (K Units)
Table 41. Americas Herceptin (Trastuzumab) Sales Market Share by Application (2017-2022)
Table 42. APAC Herceptin (Trastuzumab) Sales by Region (2017-2022) & (K Units)
Table 43. APAC Herceptin (Trastuzumab) Sales Market Share by Region (2017-2022)
Table 44. APAC Herceptin (Trastuzumab) Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Herceptin (Trastuzumab) Revenue Market Share by Region (2017-2022)
Table 46. APAC Herceptin (Trastuzumab) Sales by Type (2017-2022) & (K Units)
Table 47. APAC Herceptin (Trastuzumab) Sales Market Share by Type (2017-2022)
Table 48. APAC Herceptin (Trastuzumab) Sales by Application (2017-2022) & (K Units)
Table 49. APAC Herceptin (Trastuzumab) Sales Market Share by Application (2017-2022)
Table 50. Europe Herceptin (Trastuzumab) Sales by Country (2017-2022) & (K Units)
Table 51. Europe Herceptin (Trastuzumab) Sales Market Share by Country (2017-2022)
Table 52. Europe Herceptin (Trastuzumab) Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Herceptin (Trastuzumab) Revenue Market Share by Country (2017-2022)
Table 54. Europe Herceptin (Trastuzumab) Sales by Type (2017-2022) & (K Units)
Table 55. Europe Herceptin (Trastuzumab) Sales Market Share by Type (2017-2022)
Table 56. Europe Herceptin (Trastuzumab) Sales by Application (2017-2022) & (K Units)
Table 57. Europe Herceptin (Trastuzumab) Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Herceptin (Trastuzumab) Sales by Country (2017-2022) & (K Units)
Table 59. Middle East & Africa Herceptin (Trastuzumab) Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Herceptin (Trastuzumab) Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Herceptin (Trastuzumab) Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Herceptin (Trastuzumab) Sales by Type (2017-2022) & (K Units)
Table 63. Middle East & Africa Herceptin (Trastuzumab) Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Herceptin (Trastuzumab) Sales by Application (2017-2022) & (K Units)
Table 65. Middle East & Africa Herceptin (Trastuzumab) Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Herceptin (Trastuzumab)
Table 67. Key Market Challenges & Risks of Herceptin (Trastuzumab)
Table 68. Key Industry Trends of Herceptin (Trastuzumab)
Table 69. Herceptin (Trastuzumab) Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Herceptin (Trastuzumab) Distributors List
Table 72. Herceptin (Trastuzumab) Customer List
Table 73. Global Herceptin (Trastuzumab) Sales Forecast by Region (2023-2028) & (K Units)
Table 74. Global Herceptin (Trastuzumab) Sales Market Forecast by Region
Table 75. Global Herceptin (Trastuzumab) Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Herceptin (Trastuzumab) Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Herceptin (Trastuzumab) Sales Forecast by Country (2023-2028) & (K Units)
Table 78. Americas Herceptin (Trastuzumab) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Herceptin (Trastuzumab) Sales Forecast by Region (2023-2028) & (K Units)
Table 80. APAC Herceptin (Trastuzumab) Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Herceptin (Trastuzumab) Sales Forecast by Country (2023-2028) & (K Units)
Table 82. Europe Herceptin (Trastuzumab) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Herceptin (Trastuzumab) Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Middle East & Africa Herceptin (Trastuzumab) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Herceptin (Trastuzumab) Sales Forecast by Type (2023-2028) & (K Units)
Table 86. Global Herceptin (Trastuzumab) Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Herceptin (Trastuzumab) Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Herceptin (Trastuzumab) Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Herceptin (Trastuzumab) Sales Forecast by Application (2023-2028) & (K Units)
Table 90. Global Herceptin (Trastuzumab) Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Herceptin (Trastuzumab) Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Herceptin (Trastuzumab) Revenue Market Share Forecast by Application (2023-2028)
Table 93. Roche Diagnostics Basic Information, Herceptin (Trastuzumab) Manufacturing Base, Sales Area and Its Competitors
Table 94. Roche Diagnostics Herceptin (Trastuzumab) Product Offered
Table 95. Roche Diagnostics Herceptin (Trastuzumab) Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2020-2022)
Table 96. Roche Diagnostics Main Business
Table 97. Roche Diagnostics Latest Developments
Table 98. Genentech Basic Information, Herceptin (Trastuzumab) Manufacturing Base, Sales Area and Its Competitors
Table 99. Genentech Herceptin (Trastuzumab) Product Offered
Table 100. Genentech Herceptin (Trastuzumab) Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2020-2022)
Table 101. Genentech Main Business
Table 102. Genentech Latest Developments
Table 103. Novartis AG Basic Information, Herceptin (Trastuzumab) Manufacturing Base, Sales Area and Its Competitors
Table 104. Novartis AG Herceptin (Trastuzumab) Product Offered
Table 105. Novartis AG Herceptin (Trastuzumab) Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2020-2022)
Table 106. Novartis AG Main Business
Table 107. Novartis AG Latest Developments
Table 108. Pfizer Basic Information, Herceptin (Trastuzumab) Manufacturing Base, Sales Area and Its Competitors
Table 109. Pfizer Herceptin (Trastuzumab) Product Offered
Table 110. Pfizer Herceptin (Trastuzumab) Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2020-2022)
Table 111. Pfizer Main Business
Table 112. Pfizer Latest Developments
Table 113. Abnova Corporation Basic Information, Herceptin (Trastuzumab) Manufacturing Base, Sales Area and Its Competitors
Table 114. Abnova Corporation Herceptin (Trastuzumab) Product Offered
Table 115. Abnova Corporation Herceptin (Trastuzumab) Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2020-2022)
Table 116. Abnova Corporation Main Business
Table 117. Abnova Corporation Latest Developments
Table 118. InvivoGen Basic Information, Herceptin (Trastuzumab) Manufacturing Base, Sales Area and Its Competitors
Table 119. InvivoGen Herceptin (Trastuzumab) Product Offered
Table 120. InvivoGen Herceptin (Trastuzumab) Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2020-2022)
Table 121. InvivoGen Main Business
Table 122. InvivoGen Latest Developments
Table 123. Celltrion Basic Information, Herceptin (Trastuzumab) Manufacturing Base, Sales Area and Its Competitors
Table 124. Celltrion Herceptin (Trastuzumab) Product Offered
Table 125. Celltrion Herceptin (Trastuzumab) Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2020-2022)
Table 126. Celltrion Main Business
Table 127. Celltrion Latest Developments
Table 128. Biocon Limited Basic Information, Herceptin (Trastuzumab) Manufacturing Base, Sales Area and Its Competitors
Table 129. Biocon Limited Herceptin (Trastuzumab) Product Offered
Table 130. Biocon Limited Herceptin (Trastuzumab) Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2020-2022)
Table 131. Biocon Limited Main Business
Table 132. Biocon Limited Latest Developments
Table 133. Bio-Techne Basic Information, Herceptin (Trastuzumab) Manufacturing Base, Sales Area and Its Competitors
Table 134. Bio-Techne Herceptin (Trastuzumab) Product Offered
Table 135. Bio-Techne Herceptin (Trastuzumab) Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2020-2022)
Table 136. Bio-Techne Main Business
Table 137. Bio-Techne Latest Developments
Table 138. Amgen Basic Information, Herceptin (Trastuzumab) Manufacturing Base, Sales Area and Its Competitors
Table 139. Amgen Herceptin (Trastuzumab) Product Offered
Table 140. Amgen Herceptin (Trastuzumab) Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2020-2022)
Table 141. Amgen Main Business
Table 142. Amgen Latest Developments
Table 143. Samsung Bioepis Basic Information, Herceptin (Trastuzumab) Manufacturing Base, Sales Area and Its Competitors
Table 144. Samsung Bioepis Herceptin (Trastuzumab) Product Offered
Table 145. Samsung Bioepis Herceptin (Trastuzumab) Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2020-2022)
Table 146. Samsung Bioepis Main Business
Table 147. Samsung Bioepis Latest Developments
Table 148. Merck Basic Information, Herceptin (Trastuzumab) Manufacturing Base, Sales Area and Its Competitors
Table 149. Merck Herceptin (Trastuzumab) Product Offered
Table 150. Merck Herceptin (Trastuzumab) Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2020-2022)
Table 151. Merck Main Business
Table 152. Merck Latest Developments
Table 153. Mylan Basic Information, Herceptin (Trastuzumab) Manufacturing Base, Sales Area and Its Competitors
Table 154. Mylan Herceptin (Trastuzumab) Product Offered
Table 155. Mylan Herceptin (Trastuzumab) Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2020-2022)
Table 156. Mylan Main Business
Table 157. Mylan Latest Developments
Table 158. Teva Pharmaceutical Basic Information, Herceptin (Trastuzumab) Manufacturing Base, Sales Area and Its Competitors
Table 159. Teva Pharmaceutical Herceptin (Trastuzumab) Product Offered
Table 160. Teva Pharmaceutical Herceptin (Trastuzumab) Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2020-2022)
Table 161. Teva Pharmaceutical Main Business
Table 162. Teva Pharmaceutical Latest Developments
Table 163. Mundipharma Basic Information, Herceptin (Trastuzumab) Manufacturing Base, Sales Area and Its Competitors
Table 164. Mundipharma Herceptin (Trastuzumab) Product Offered
Table 165. Mundipharma Herceptin (Trastuzumab) Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2020-2022)
Table 166. Mundipharma Main Business
Table 167. Mundipharma Latest Developments
Table 168. Mabion Basic Information, Herceptin (Trastuzumab) Manufacturing Base, Sales Area and Its Competitors
Table 169. Mabion Herceptin (Trastuzumab) Product Offered
Table 170. Mabion Herceptin (Trastuzumab) Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2020-2022)
Table 171. Mabion Main Business
Table 172. Mabion Latest Developments
Table 173. AryoGen Biopharma Basic Information, Herceptin (Trastuzumab) Manufacturing Base, Sales Area and Its Competitors
Table 174. AryoGen Biopharma Herceptin (Trastuzumab) Product Offered
Table 175. AryoGen Biopharma Herceptin (Trastuzumab) Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2020-2022)
Table 176. AryoGen Biopharma Main Business
Table 177. AryoGen Biopharma Latest Developments
Table 178. Genor Biopharma Basic Information, Herceptin (Trastuzumab) Manufacturing Base, Sales Area and Its Competitors
Table 179. Genor Biopharma Herceptin (Trastuzumab) Product Offered
Table 180. Genor Biopharma Herceptin (Trastuzumab) Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2020-2022)
Table 181. Genor Biopharma Main Business
Table 182. Genor Biopharma Latest Developments
List of Figures
Figure 1. Picture of Herceptin (Trastuzumab)
Figure 2. Herceptin (Trastuzumab) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Herceptin (Trastuzumab) Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Herceptin (Trastuzumab) Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Herceptin (Trastuzumab) Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Breast Cancer
Figure 10. Product Picture of Stomach Cancer
Figure 11. Product Picture of Others
Figure 12. Global Herceptin (Trastuzumab) Sales Market Share by Type in 2021
Figure 13. Global Herceptin (Trastuzumab) Revenue Market Share by Type (2017-2022)
Figure 14. Herceptin (Trastuzumab) Consumed in Hospital
Figure 15. Global Herceptin (Trastuzumab) Market: Hospital (2017-2022) & (K Units)
Figure 16. Herceptin (Trastuzumab) Consumed in Medical Center
Figure 17. Global Herceptin (Trastuzumab) Market: Medical Center (2017-2022) & (K Units)
Figure 18. Global Herceptin (Trastuzumab) Sales Market Share by Application (2017-2022)
Figure 19. Global Herceptin (Trastuzumab) Revenue Market Share by Application in 2021
Figure 20. Herceptin (Trastuzumab) Revenue Market by Company in 2021 ($ Million)
Figure 21. Global Herceptin (Trastuzumab) Revenue Market Share by Company in 2021
Figure 22. Global Herceptin (Trastuzumab) Sales Market Share by Geographic Region (2017-2022)
Figure 23. Global Herceptin (Trastuzumab) Revenue Market Share by Geographic Region in 2021
Figure 24. Global Herceptin (Trastuzumab) Sales Market Share by Region (2017-2022)
Figure 25. Global Herceptin (Trastuzumab) Revenue Market Share by Country/Region in 2021
Figure 26. Americas Herceptin (Trastuzumab) Sales 2017-2022 (K Units)
Figure 27. Americas Herceptin (Trastuzumab) Revenue 2017-2022 ($ Millions)
Figure 28. APAC Herceptin (Trastuzumab) Sales 2017-2022 (K Units)
Figure 29. APAC Herceptin (Trastuzumab) Revenue 2017-2022 ($ Millions)
Figure 30. Europe Herceptin (Trastuzumab) Sales 2017-2022 (K Units)
Figure 31. Europe Herceptin (Trastuzumab) Revenue 2017-2022 ($ Millions)
Figure 32. Middle East & Africa Herceptin (Trastuzumab) Sales 2017-2022 (K Units)
Figure 33. Middle East & Africa Herceptin (Trastuzumab) Revenue 2017-2022 ($ Millions)
Figure 34. Americas Herceptin (Trastuzumab) Sales Market Share by Country in 2021
Figure 35. Americas Herceptin (Trastuzumab) Revenue Market Share by Country in 2021
Figure 36. United States Herceptin (Trastuzumab) Revenue Growth 2017-2022 ($ Millions)
Figure 37. Canada Herceptin (Trastuzumab) Revenue Growth 2017-2022 ($ Millions)
Figure 38. Mexico Herceptin (Trastuzumab) Revenue Growth 2017-2022 ($ Millions)
Figure 39. Brazil Herceptin (Trastuzumab) Revenue Growth 2017-2022 ($ Millions)
Figure 40. APAC Herceptin (Trastuzumab) Sales Market Share by Region in 2021
Figure 41. APAC Herceptin (Trastuzumab) Revenue Market Share by Regions in 2021
Figure 42. China Herceptin (Trastuzumab) Revenue Growth 2017-2022 ($ Millions)
Figure 43. Japan Herceptin (Trastuzumab) Revenue Growth 2017-2022 ($ Millions)
Figure 44. South Korea Herceptin (Trastuzumab) Revenue Growth 2017-2022 ($ Millions)
Figure 45. Southeast Asia Herceptin (Trastuzumab) Revenue Growth 2017-2022 ($ Millions)
Figure 46. India Herceptin (Trastuzumab) Revenue Growth 2017-2022 ($ Millions)
Figure 47. Australia Herceptin (Trastuzumab) Revenue Growth 2017-2022 ($ Millions)
Figure 48. Europe Herceptin (Trastuzumab) Sales Market Share by Country in 2021
Figure 49. Europe Herceptin (Trastuzumab) Revenue Market Share by Country in 2021
Figure 50. Germany Herceptin (Trastuzumab) Revenue Growth 2017-2022 ($ Millions)
Figure 51. France Herceptin (Trastuzumab) Revenue Growth 2017-2022 ($ Millions)
Figure 52. UK Herceptin (Trastuzumab) Revenue Growth 2017-2022 ($ Millions)
Figure 53. Italy Herceptin (Trastuzumab) Revenue Growth 2017-2022 ($ Millions)
Figure 54. Russia Herceptin (Trastuzumab) Revenue Growth 2017-2022 ($ Millions)
Figure 55. Middle East & Africa Herceptin (Trastuzumab) Sales Market Share by Country in 2021
Figure 56. Middle East & Africa Herceptin (Trastuzumab) Revenue Market Share by Country in 2021
Figure 57. Egypt Herceptin (Trastuzumab) Revenue Growth 2017-2022 ($ Millions)
Figure 58. South Africa Herceptin (Trastuzumab) Revenue Growth 2017-2022 ($ Millions)
Figure 59. Israel Herceptin (Trastuzumab) Revenue Growth 2017-2022 ($ Millions)
Figure 60. Turkey Herceptin (Trastuzumab) Revenue Growth 2017-2022 ($ Millions)
Figure 61. GCC Country Herceptin (Trastuzumab) Revenue Growth 2017-2022 ($ Millions)
Figure 62. Manufacturing Cost Structure Analysis of Herceptin (Trastuzumab) in 2021
Figure 63. Manufacturing Process Analysis of Herceptin (Trastuzumab)
Figure 64. Industry Chain Structure of Herceptin (Trastuzumab)
Figure 65. Channels of Distribution
Figure 66. Distributors Profiles
